Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2010; 31(02): 69-71
DOI: 10.4103/0971-5851.71660
CASE REPORT

Youngest case of third ventricular anaplastic neurocytoma

Shravan Kumar Chinnikatti
Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
D N Sharma
Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
Kuldeep Sharma
Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
K P Haresh
Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
G K Rath
Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations Source of Support Nil.
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

A 6-year-old child presented to us with on and off headache and vomiting for 4 months. On examination, there was bilateral papilledema with mild intracranial hypertension but with no neurological deficits. Magnetic resonance imaging (MRI) showed third ventricular mass with obstructive hydrocephalus with possibility of glioma. The patient underwent gross tumor excision and histopathology confirmed anaplastic neurocytoma. The postoperative MRI showed residual disease. The patient treated with adjuvant radiotherapy and temozolamide chemotherapy.

Keywords

Anaplastic neurocytoma - MIB-1 labeling index - radiotherapy - synaptophysin - temozolamide


Publication History

Article published online:
19 November 2021

© 2010. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Vallat-Decouvelaere AV, Gauchez P, Varlet P, Delisle MB, Popovic M, Boissonnet H, et al. So called malignant and extra-ventricular neurocytomas: Reality or wrong diagnosis?A critical review about two overdiagnosed cases. J Neurooncol 2000;48:161-72.
  • 2 Dirk R, Fabian F, Steven E. Schild, Original article treatment of atypical neurocytomas, Cancer 2004;100:814-7
  • 3 Söylemezoglu F, Scheithauer BW, Esteve J, Kleihues P. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997;56:551-6.
  • 4 Brat DJ, Scheithauer BW, Eberhart CG, Burger PC. Extraventricular neurocytomas: Pathologic features and clinical outcome. Am J Surg Pathol 2001;25:1252-60.
  • 5 Sgouros S, Carey M, Aluwihare N, Barber P, Jackowski A. Central neurocytoma: A correlative clinicopathologic and radiologic analysis. Surg Neurol 1998;49:197-204.
  • 6 Sharma MC, Rathore A, Karak AK, Sarkar C. A study of proliferative markers in central neurocytoma. Pathology 1998;30:355-9.
  • 7 Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997;56:551-6.
  • 8 Mackenzie IR. Central neurocytoma: Histologic atypia, proliferation potential, and clinical outcome. Cancer 1999;85:1606-10.
  • 9 Ashkan K, Casey AT, D′Arrigo C, Harkness WF, Thomas DG. Benign central neurocytoma . Cancer 2000;89:1111-20.
  • 10 Brandes AA, Amista P, Gardiman M, Volpin L, Danieli D, Guglielmi B, et al. Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer 2000;88:169-74.